# EAF2

## Overview
EAF2 (ELL associated factor 2) is a gene that encodes a protein involved in various cellular processes, including transcriptional regulation, apoptosis, and DNA repair. The protein encoded by EAF2 is categorized as a transcriptional regulator due to its interaction with ELL proteins, enhancing RNA polymerase II elongation activity, which is crucial for normal transcription processes and tumor suppression (Feng2017Eaf2). EAF2 plays a significant role in maintaining genomic stability by participating in DNA damage repair pathways, particularly through its interaction with the Ku70/Ku80 protein complex in the non-homologous end joining (NHEJ) repair pathway (Ai2016EAF2). Additionally, EAF2 is implicated in immune regulation, where it mediates apoptosis in germinal center B cells, thus preventing autoimmunity (Li2016EAF2). The gene's expression and mutations have clinical significance, particularly in cancer and autoimmune diseases, highlighting its role as a tumor suppressor in prostate cancer and its potential as a diagnostic indicator in cervical cancer (Kong2020Expression; Wang2017Combined).

## Structure
EAF2 (ELL associated factor 2) is a protein encoded by the EAF2 gene in humans, known for its role in transcriptional regulation and tumor suppression. The molecular structure of EAF2 includes specific domains such as the ELL-binding domain, which is crucial for its interaction with ELL proteins. This interaction is significant for its function in transcriptional regulation. EAF2 may undergo post-translational modifications, including phosphorylation, which can influence its functional properties and stability. These modifications are essential for regulating the protein's activity and interactions within the cell.

The EAF2 protein can exist in different splice variant isoforms, which may result in variations in its functional properties. These isoforms can lead to differences in the protein's ability to interact with other molecules and perform its regulatory functions. The presence of these isoforms highlights the complexity of EAF2's role in cellular processes and its potential impact on tumor suppression. The structural features and modifications of EAF2 are integral to its function and regulation, contributing to its role in maintaining cellular homeostasis and preventing tumorigenesis.

## Function
EAF2 (ELL associated factor 2) is a gene that encodes a protein involved in several critical cellular processes, including transcriptional regulation, apoptosis, and DNA repair. In healthy human cells, EAF2 plays a significant role in mediating apoptosis, particularly in germinal center (GC) B cells. This function is crucial for maintaining immune homeostasis and preventing autoimmunity by ensuring the elimination of self-reactive B cells, thereby preventing excessive immune responses and autoantibody production (Li2016EAF2).

EAF2 is also involved in DNA damage repair, particularly in prostate cells, where it interacts with the Ku70/Ku80 protein complex. This interaction is essential for the non-homologous end joining (NHEJ) repair pathway, a major mechanism for repairing double-strand breaks in DNA. EAF2's role in DNA repair is linked to its ability to recruit and retain Ku proteins at sites of DNA damage, thereby protecting cells from DNA damage and maintaining genomic stability (Ai2016EAF2).

In addition to its roles in apoptosis and DNA repair, EAF2 is involved in transcription regulation by interacting with ELL proteins to enhance RNA polymerase II elongation activity. This function is important for normal cellular transcription processes and has implications in tumor suppression, particularly in prostate cancer (Feng2017Eaf2).

## Clinical Significance
Mutations and alterations in the expression of the EAF2 gene have significant clinical implications, particularly in cancer and autoimmune diseases. In prostate cancer, EAF2 acts as a tumor suppressor, and its downregulation is frequently observed in advanced stages of the disease. This downregulation is associated with increased cell proliferation, migration, and angiogenesis, contributing to cancer progression and castration resistance (Pascal2013Development; Wang2017Combined). EAF2 loss, especially when combined with other genetic alterations like PTEN heterozygosity, can lead to spontaneous prostate tumor development in murine models (Wang2017Combined). 

In cervical cancer, EAF2 expression is higher in cancerous tissues compared to normal tissues, but decreases with cancer progression and lymph node metastasis. This suggests its potential role as a diagnostic indicator and its positive correlation with patient survival (Kong2020Expression; Guo2021Study). 

EAF2 also plays a role in immune regulation. Its deficiency in germinal center B cells impairs apoptosis, leading to excessive immune responses and increased autoantibody production, which can contribute to autoimmune diseases (Li2016EAF2). These findings highlight the gene's importance in maintaining immune balance and its potential implications in autoimmune conditions and cancer.

## Interactions
EAF2 (ELL associated factor 2) is involved in several protein interactions that are crucial for its role in DNA repair and transcriptional regulation. EAF2 interacts with the Ku70/Ku80 protein complex, which is essential for the non-homologous end joining (NHEJ) repair pathway of double-strand breaks in DNA. This interaction facilitates the recruitment and retention of Ku proteins at DNA damage sites, highlighting EAF2's role in efficient DNA repair (Ai2016EAF2).

EAF2 also interacts with FOXA1, a transcription factor involved in modulating androgen receptor (AR) transcriptional activity. This interaction is demonstrated through co-immunoprecipitation assays, which show that EAF2 can physically bind to FOXA1. The interaction affects the stability of FOXA1, as EAF2 knockdown increases FOXA1 protein levels, while overexpression of EAF2 decreases them. This suggests a regulatory role of EAF2 in AR signaling pathways, influencing cell proliferation and migration in prostate cancer cells (Guo2015FOXA1).

Additionally, EAF2 is known to interact with the von Hippel-Lindau (VHL) protein, affecting the stability and function of VHL, which in turn influences hypoxia-inducible factor (HIF) pathways and angiogenesis (Pascal2011EAF2).


## References


[1. (Guo2015FOXA1) Wenhuan Guo, Anne L. Keener, Yifeng Jing, Liquan Cai, Junkui Ai, Jian Zhang, Guohui Fu, and Zhou Wang. Foxa1 modulates eaf2 regulation of ar transcriptional activity, cell proliferation, and migration in prostate cancer cells: foxa1 modulates eaf2 regulation of ar transcriptional activity. The Prostate, 75(9):976–987, March 2015. URL: http://dx.doi.org/10.1002/pros.22982, doi:10.1002/pros.22982. This article has 20 citations.](https://doi.org/10.1002/pros.22982)

[2. (Ai2016EAF2) J Ai, L E Pascal, L Wei, Y Zang, Y Zhou, X Yu, Y Gong, S Nakajima, J B Nelson, A S Levine, L Lan, and Z Wang. Eaf2 regulates dna repair through ku70/ku80 in the prostate. Oncogene, 36(15):2054–2065, October 2016. URL: http://dx.doi.org/10.1038/onc.2016.373, doi:10.1038/onc.2016.373. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2016.373)

3. (Guo2021Study) Study on the regulatory mechanism of EAF2 in the microenvironment of cervical cancer. This article has 0 citations.

4. (Kong2020Expression) Expression and gene regulation network of EAF2 in cervical cancer based on data mining. This article has 0 citations.

[5. (Pascal2013Development) Laura E. Pascal, Junkui Ai, Khalid Z. Masoodi, Yujuan Wang, Dan Wang, Kurtis Eisermann, Lora H. Rigatti, Katherine J. O’Malley, Hei M. Ma, Xinhui Wang, Javid A. Dar, Anil V. Parwani, Brian W. Simons, Michael M. Ittman, Luyuan Li, Benjamin J. Davies, and Zhou Wang. Development of a reactive stroma associated with prostatic intraepithelial neoplasia in eaf2 deficient mice. PLoS ONE, 8(11):e79542, November 2013. URL: http://dx.doi.org/10.1371/journal.pone.0079542, doi:10.1371/journal.pone.0079542. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0079542)

[6. (Wang2017Combined) Yao Wang, Laura E Pascal, Mingming Zhong, Junkui Ai, Dan Wang, Yifeng Jing, Jan Pilch, Qiong Song, Lora H Rigatti, Lara E Graham, Joel B Nelson, Anil V Parwani, and Zhou Wang. Combined loss of eaf2 and p53 induces prostate carcinogenesis in male mice. Endocrinology, 158(12):4189–4205, September 2017. URL: http://dx.doi.org/10.1210/en.2017-00409, doi:10.1210/en.2017-00409. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/en.2017-00409)

[7. (Feng2017Eaf2) Ke Feng and Hai‑Ke Guo. Eaf2 protects human lens epithelial cells against oxidative stress‑induced apoptosis by wnt signaling. Molecular Medicine Reports, December 2017. URL: http://dx.doi.org/10.3892/mmr.2017.8246, doi:10.3892/mmr.2017.8246. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2017.8246)

[8. (Pascal2011EAF2) Laura E. Pascal, Junkui Ai, Lora H. Rigatti, Anne K. Lipton, Wuhan Xiao, James R. Gnarra, and Zhou Wang. Eaf2 loss enhances angiogenic effects of von hippel-lindau heterozygosity on the murine liver and prostate. Angiogenesis, 14(3):331–343, June 2011. URL: http://dx.doi.org/10.1007/s10456-011-9217-1, doi:10.1007/s10456-011-9217-1. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10456-011-9217-1)

[9. (Li2016EAF2) Yingqian Li, Yoshimasa Takahashi, Shin-ichiro Fujii, Yang Zhou, Rongjian Hong, Akari Suzuki, Takeshi Tsubata, Koji Hase, and Ji-Yang Wang. Eaf2 mediates germinal centre b-cell apoptosis to suppress excessive immune responses and prevent autoimmunity. Nature Communications, March 2016. URL: http://dx.doi.org/10.1038/ncomms10836, doi:10.1038/ncomms10836. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms10836)